NGF/TRKA signalling (via PI3K/AKT and MAPK/ERK pathways) increases the expression of oncoproteins such as survivin and β-catenin, in cancer cells [11,12,13,14,15], and these two proteins are also upregulated in EOC [16,17]. This evidence concerns the gene NGF and cancer.